Investor Relations

Approved investment of the Utility Provider and Infrastructure for Nakhonsawan Biocomplex Phase 2 (NBC Phase 2)

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021

Financial Performance Quarter 2 (F45) (Reviewed)

Financial Statement Quarter 2/2021 (Reviewed)

Resolutions of the Board of Directors' Meeting regarding the enter into connected transaction

Report of the utilization of capital increase from IPO

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2021

Financial Performance Quarter 1 (F45) (Reviewed)

Financial Statement Quarter 1/2021 (Reviewed)

Appointment of Directors as Sub Committees Members (Revised)

Appointment of Directors as Sub Committees Members

Appointment of Director

Disclose of the Minutes of the 2021 Annual General Meeting of Shareholders on the Company's Website

Shareholders meeting's resolution

Update on Proceedings in Respect of Missing Inventory Incident

Notice of Change of Venue for the 2021 Annual General Meeting of Shareholders and Disclose the Notice of the 2021 Annual General Meeting of Shareholders on Website (Edited)

Notice of Change of Venue for the 2020 Annual General Meeting of Shareholders and Disclose the Notice of the 2021 Annual General Meeting of Shareholders on Website

Notice of Change of Venue for the 2020 Annual General Meeting of Shareholders and Disclose the Notice of the 2021 Annual General Meeting of Shareholders on Website

Date and Agenda for the 2021 Annual General Meeting of Shareholders, and Dividend Payment

Management Discussion and Analysis Yearly Ending 31 Dec 2020